<code id='3C1986382A'></code><style id='3C1986382A'></style>
    • <acronym id='3C1986382A'></acronym>
      <center id='3C1986382A'><center id='3C1986382A'><tfoot id='3C1986382A'></tfoot></center><abbr id='3C1986382A'><dir id='3C1986382A'><tfoot id='3C1986382A'></tfoot><noframes id='3C1986382A'>

    • <optgroup id='3C1986382A'><strike id='3C1986382A'><sup id='3C1986382A'></sup></strike><code id='3C1986382A'></code></optgroup>
        1. <b id='3C1986382A'><label id='3C1986382A'><select id='3C1986382A'><dt id='3C1986382A'><span id='3C1986382A'></span></dt></select></label></b><u id='3C1986382A'></u>
          <i id='3C1986382A'><strike id='3C1986382A'><tt id='3C1986382A'><pre id='3C1986382A'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:leisure time    Page View:7
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In